Novel uses for recombinant erythropoietin therapy in unlicensed indications. [electronic resource]
- The hematology journal : the official journal of the European Haematology Association 2004
- 181-5 p. digital
Publication Type: Journal Article
1466-4860
10.1038/sj.thj.6200350 doi
Adult Aged Anemia--blood Antineoplastic Agents--adverse effects Blood Group Antigens Drug Approval Erythropoietin--therapeutic use Female Hemolysis Humans Kidney Failure, Chronic--complications Middle Aged Neoplasms--complications Recombinant Proteins Transfusion Reaction